Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019
Quinn T. Ostrom, Mackenzie Price, Corey Neff, et al.
Neuro-Oncology (2022) Vol. 24, Iss. Supplement_5, pp. v1-v95
Open Access | Times Cited: 932

Showing 1-25 of 932 citing articles:

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020
Quinn T. Ostrom, Mackenzie Price, Corey Neff, et al.
Neuro-Oncology (2023) Vol. 25, Iss. Supplement_4, pp. iv1-iv99
Open Access | Times Cited: 596
Glioblastoma and Other Primary Brain Malignancies in Adults
Lauren Schaff, Ingo K. Mellinghoff
JAMA (2023) Vol. 329, Iss. 7, pp. 574-574
Closed Access | Times Cited: 488
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 33, pp. 5187-5199
Open Access | Times Cited: 153
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 79
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019
David A. Siegel, Jessica King, Philip J. Lupo, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1337-1354
Open Access | Times Cited: 59
2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review
Diana Thomas
Chinese Clinical Oncology (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 57
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 56
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
William Chen, Abrar Choudhury, Mark W. Youngblood, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3067-3076
Open Access | Times Cited: 54
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment
Sirvan Khalighi, Kartik Reddy, Abhishek Midya, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Recurrent Glioblastoma: A Review of the Treatment Options
Maria Angeles Vaz-Salgado, María Villamayor, Víctor Albarrán, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4279-4279
Open Access | Times Cited: 44
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 34
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017–2021
Mackenzie Price, Christine Ann Pittman Ballard, Julia Benedetti, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_6, pp. vi1-vi85
Open Access | Times Cited: 30
Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma
LI Guan-zhang, Di Wang, You Zhai, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1696-1710.e10
Open Access | Times Cited: 24
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 22
Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy
Yaoqiang Du, Rusong Li, Danqing Fu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 18
Glioblastoma and brain connectivity: the need for a paradigm shift
Alessandro Salvalaggio, Lorenzo Pini, Alessandra Bertoldo, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 7, pp. 740-748
Closed Access | Times Cited: 16
Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning
Divyanshu Tak, Zezhong Ye, Anna Zapaischykova, et al.
Radiology Artificial Intelligence (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 15
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z. Wang, Vikas Patil, Alexander Landry, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3173-3183
Open Access | Times Cited: 15
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Edward K. Avila, Steven Tobochnik, Sara K. Inati, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 1, pp. 7-24
Open Access | Times Cited: 35
IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
Serena Ammendola, Giuseppe Broggi, Valeria Barresi
PubMed (2023) Vol. 38, Iss. 7, pp. 739-753
Closed Access | Times Cited: 32
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
Ahmad Ozair, Vivek Bhat, Reid S. Alisch, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1342-1342
Open Access | Times Cited: 29
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
Matthew T. Ballo, Patrick R. Conlon, Gitit Lavy-Shahaf, et al.
Journal of Neuro-Oncology (2023) Vol. 164, Iss. 1, pp. 1-9
Open Access | Times Cited: 28
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Grayson Herrgott, James M. Snyder, Ruicong She, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Neuron–oligodendroglial interactions in health and malignant disease
Kathryn R. Taylor, Michelle Monje
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 12, pp. 733-746
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top